The Management of Lower Urinary Tract Obstruction in Patients with Advanced Prostate Cancer
DOI:
https://doi.org/10.6000/1927-7229.2015.04.03.2Keywords:
Non-small-cell lung carcinoma, EGFR, wild-type, erlotinib, second-line.Abstract
Objectives: To determine the optimal time to wait for urination ability restoration after urethral catheterization and anti - androgen treatment, in cases of acute urinary retention and advanced prostate cancer.
Methods: We enrolled 26 patients with histologically confirmed prostate cancer after transrectal ultrasound guided biopsy of the prostate and CT or MRI proven advanced stages (T3-T4). We evaluated the dynamic changes of the following factors; IPSS, QoL, Vmax, residual urine, serum concentration of PSA at the following periods; before hormonal treatment, 1, 3 and 6 months after hormonal treatment.
Results: How long we have to wait after urethral catheter insertion and hormonal treatment for voiding ability restoration?
Our data analyses revealed the answer to this question. The dynamic changes of all the parameters (IPSS, QoL, Vmax, PSA) we studied disclosed interesting regularity. The consequent comparative analyses of parameters showed statistically significant changes only 1 month after anti - androgen treatment. These changes indicate that the prostate cancerous process is significantly suppressed within 1 month after hormonal treatment and there is no point to wait more than 1 month.
Conclusion: Analyzing our data we obtained versatile evidence, that in advanced prostate cancer and acute urinary retention cases the optimal time to wait for sufficient voiding is 1 month period after permanent catheter insertion and anti - androgen treatment.
References
Matveev VB. Screening of prostate cancer. Is it needed? Russian experience. Arch Ital Urol Androl 2006; 78(4): 149-51.
Varenhorst E, Alund G. Urethral obstruction secondary to carcinoma of prostate: response to endocrine treatment. Urology 1985; 25: 345-56. http://dx.doi.org/10.1016/0090-4295(85)90485-6
Sehgal A, Mandhani A, Gupta N, Dubey D, Srivastava A, Kapoor R, Kumar A. Can the need for palliative transurethral prostatic resection in patients with advanced carcinoma of the prostate be predicted? J Endourol 2005; 19(5): 546-9. http://dx.doi.org/10.1089/end.2005.19.546
Mommsen S, Petersen L. Transurethral catheter removal after bilateral orchiectomy for prostatic carcinoma associated with acute urinary retention. Scand J Urol Nephrol 1994; 28(4): 401-4. http://dx.doi.org/10.3109/00365599409180520
Gleave ME, Goldenberg SL, Jones EC, et al. Optimal duration of neoadjuvant androgen withdrawal therapy before radical prostatectomy in clinically confined prostate cancer. Sem Urol Oncol 1996; 14(suppl 2): 39-47.
Crawford ED, Eisenburger MA, McLeod DG, et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 1989; 321: 419-24. http://dx.doi.org/10.1056/NEJM198908173210702
Chute R, Willetts AT, Gens JP. Experiences in the treatment of carcinoma of the prostate with stilbestrol and with castration by the technique of intra-capsular orchidectomy. J Urol 1942; 48: 682.
Vaillancourt L, Tetu B, Fradet Y, et al. Effect of neoadjuvant endocrine therapy (combined androgen blockage) on normal prostate and prostatic carcinoma. J Surg Pathol 1996; 20: 86-93. http://dx.doi.org/10.1097/00000478-199601000-00010
Fleischmann JD, Catalona WJ. Endocrine therapy for bladder outlet obstruction from carcinoma of the prostate. J Urol 1985; 134: 498-500.
Thomas DJ, Balaji VJ, Coptcoat MJ, Abercrombie GF. Acute urinary retention secondary to carcinoma of the prostate. Is initial channel TURP beneficial? J Roy Soc Med 1992; 85(3): 318-19.
Varenhorst E, Alund G. Urethral obstruction secondary to carcinoma of prostate: response to endocrine treatment. Urology 1985; 25: 345-56. http://dx.doi.org/10.1016/0090-4295(85)90485-6
Carpentier PJ, Schroder FH. Transrectal ultrasonography in the followup of prostatic carcinoma patients: a new prognostic parameter? J Urol 1984; 131: 903-5.
Downloads
Published
Issue
Section
How to Cite
Similar Articles
- Alireza Heidari, Katrina Schmitt, Maria Henderson, Elizabeth Besana, Effectiveness of Einsteinium Nanoparticles in Optothermal Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron Radiation , Journal of Analytical Oncology: Vol. 8 (2019)
- Darrell B. Tata, Ilko K. Ilev, Non-Invasive Real-Time Monitoring and Label-Free Sensing of Hydrogen Peroxide in Human Brain Cancer Cells Through Raman Spectroscopy , Journal of Analytical Oncology: Vol. 1 No. 2 (2012)
- Kanupriya Gupta, Jatin Gupta, Rahul Agrawal, Neha Verma, Quantitative Analysis of Mast Cells in Benign Odontogenic Tumors , Journal of Analytical Oncology: Vol. 8 (2019)
- T.G. Shrihari, Myeloid Derived Suppressor Cells in Oral Cancer: An Emerging Concept , Journal of Analytical Oncology: Vol. 7 No. 2 (2018)
- Adilson Domingos dos Reis Filho, Fernando Tadeu Trevisan Frajacomo, Roberto Carlos Vieira Junior, Haracelli Christina Barbosa Alves Leite da Costa, James Wilfred Navalta, Ramires Alsamir Tibana, Jonato Prestes, Fabrício Azevedo Voltarelli, Strength Training as an Adjunct to the Maintenance of Muscle Mass in Patients with Head and Neck Cancer , Journal of Analytical Oncology: Vol. 7 No. 2 (2018)
- Karl Andersson, Bringing Time into Molecular and Cellular Biology , Journal of Analytical Oncology: Vol. 2 No. 2 (2013)
- P. Mehdipour, F. Javan, M. Faghih Jouibari, M. Khaleghi, Metastatic Model of Cerebellar Medulloblastoma Cells to Peritoneal Cavity: Exploration of Circulating Tumor Cells , Journal of Analytical Oncology: Vol. 10 (2021)
- Antonieta Salud, Vicente Alonso, Pilar Escudero, Miguel Burillo, Cristina Martín, Fernando Rivera, Alfonso Yubero, Carlos García-Girón, Alberto Muñoz, Phase II Study of Irinotecan in Combination with Capecitabine on a 3-Weekly Schedule as First-Line Chemotherapy for Patients with Metastatic or Locally Advanced Colorectal Cancer , Journal of Analytical Oncology: Vol. 2 No. 3 (2013)
- Ahmad Salimi, Mehrnoush Pir Saharkhiz, Abbasali Motallebi, Enayatollah Seydi, Ali Reza Mohseni, Melika Nazemi , Jalal Pourahmad, Standardized Extract of the Persian Gulf Sponge, Axinella Sinoxea Selectively Induces Apoptosis through Mitochondria in Human Chronic Lymphocytic Leukemia Cells , Journal of Analytical Oncology: Vol. 4 No. 4 (2015)
- Lies Pottel, Michelle Lycke, Tom Boterberg, Lore Ketelaars, Hans Pottel, Laurence Goethals, Nele Van den Noortgate, Fréderic Duprez, Wilfried De Neve, Sylvie Rottey, Kurt Geldhof, Koen Van Eygen, Khalil Kargar-Samani, Véronique Ghekiere, Anne Verhaeghe, Philip R. Debruyne, Experience with Lexicomp® Online Drug Database for Medication Review and Drug-Drug Interaction Analysis within a Comprehensive Geriatric Assessment in Elderly Cancer Patients , Journal of Analytical Oncology: Vol. 1 No. 1 (2012)
You may also start an advanced similarity search for this article.